Literature DB >> 24395198

Sjögren's syndrome accompanied with interstitial cystitis: a case report and review of the literature.

Dongfeng Liang1, Jinshan Lu, Aitao Guo.   

Abstract

We present a case report of a patient with Sjögren's syndrome accompanied with interstitial cystitis. A 64-year-old woman complained of dry mouth for 21 years, recurrent swelling and pain on the right parotid in 2000, and urinary irritation symptoms in the past 2 years. Several courses of different types of antibiotics could not relieve her urinary irritation symptoms. Bladder hydraulic dilatation had only transient effects. Urine sediment contained neither erythrocytes nor leukocytes, and urine cultures yielded no growth. However, increased γ-globulin, positive antinuclear antibodies, and anti-SS-A and anti-SS-B antibodies were detected. Histopathological data of labial salivary glands showed three foci of numerous mononuclear cells. Cystoscopy revealed redness, edema, angiectasis, and extensive ecchymosis of the mucosal surface and several small floating cruor entities in the bladder. Urinary bladder biopsy specimens revealed the absence of urothelium and edematous lamina propria and submucosa, with diffuse or multiple focal chronic inflammatory cell infiltration. Based on these findings, she was diagnosed with Sjögren's syndrome accompanied with interstitial cystitis. Therapy with corticosteroids relieved the symptoms significantly.

Entities:  

Mesh:

Year:  2014        PMID: 24395198     DOI: 10.1007/s10067-013-2480-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  31 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

Review 2.  [Central and peripheral neurologic lesions in primary Gougerot-Sjögren syndrome. Clinicopathological study of a case].

Authors:  S Bakchine; C Duyckaerts; L Hassine; M P Chaunu; E Turell; B Wechsler; F Chain
Journal:  Rev Neurol (Paris)       Date:  1991       Impact factor: 2.607

Review 3.  Interstitial cystitis and systemic autoimmune diseases.

Authors:  Joop P van de Merwe
Journal:  Nat Clin Pract Urol       Date:  2007-09

4.  A diffuse T lymphocytic gastrointestinal mucosal infiltration associated with Sjögren's syndrome resulting in a watery diarrhea syndrome and responsive to immunosuppressive therapy.

Authors:  I Sobhani; N Brousse; C Vissuzaine; E Mcintyre; J P Marmuse; M F Kahn; F Potet; M Mignon
Journal:  Am J Gastroenterol       Date:  1998-12       Impact factor: 10.864

5.  Lower urinary tract symptoms in patients with Sjögren's syndrome and systemic lupus erythematosus.

Authors:  M Haarala; A Alanen; M Hietarinta; P Kiilholma
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2000

Review 6.  Primary Sjogren syndrome: clinical and immunopathologic features.

Authors:  R I Fox; F V Howell; R C Bone; P Michelson
Journal:  Semin Arthritis Rheum       Date:  1984-11       Impact factor: 5.532

7.  Passive transfer of Sjogren's syndrome IgG produces the pathophysiology of overactive bladder.

Authors:  Fang Wang; Michael W Jackson; Vicki Maughan; Dana Cavill; Anthony J Smith; Sally A Waterman; Tom P Gordon
Journal:  Arthritis Rheum       Date:  2004-11

8.  Clinically significant and biopsy-documented renal involvement in primary Sjögren syndrome.

Authors:  A Goules; S Masouridi; A G Tzioufas; J P Ioannidis; F N Skopouli; H M Moutsopoulos
Journal:  Medicine (Baltimore)       Date:  2000-07       Impact factor: 1.889

9.  Autoantibodies in interstitial cystitis.

Authors:  R L Ochs; T W Stein; C L Peebles; R F Gittes; E M Tan
Journal:  J Urol       Date:  1994-03       Impact factor: 7.450

10.  Interstitial cystitis: a rare manifestation of primary Sjögren's syndrome, successfully treated with low dose cyclosporine.

Authors:  Hakan Emmungil; Melike Kalfa; Figen Yargucu Zihni; Gonca Karabulut; Gokhan Keser; Sait Sen; Kenan Aksu
Journal:  Rheumatol Int       Date:  2011-01-22       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.